Neeraj Agarwal, Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), shared a post on LinkedIn:
“I’m honored to share that I am on the 2026 ASCO ballot for a seat on the Nominating Committee.
Over nearly two decades with ASCO, I’ve served as Editor-in-Chief of ASCO Daily News, on the Communications Committee, and on Conquer Cancer Foundation grant review panels. These roles, along with collaborations across SWOG, NCCN, PCF, and global partners, have strengthened my commitment to fair, thoughtful leadership that reflects our diverse oncology community and supports the next generation of investigators.
More information about the candidates and voting can be found here.
Thank you for your support.”
Ravindran Kanesvaran, Chair and Senior Consultant at Division of Medical Oncology, National Cancer Centre Singapore, shared this post adding:
“Pleased to support Prof Neeraj Agarwal, MD, FASCO for the 2026 ASCO Nominating Committee.
His decades of service—from ASCO Daily News leadership to collaborative work across SWOG, NCCN, and global partners—reflect integrity, inclusivity, and commitment to advancing oncology. A strong advocate for our next generation of investigators and clinicians alike.“
More posts featuring Neeraj Agarwal and Ravindran Kanesvaran.